(Q44404530)

English

A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patients

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jon Karnon

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Trefor Jones

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

513-525

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200321070-00006

0 references

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on endocrine therapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Handling uncertainty in cost-effectiveness models

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ABC of breast diseases. Metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity analysis and the expected value of perfect information

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of aromatase inhibitors in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of letrozole in the treatment of advanced breast cancer in postmenopausal women in the UK.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine therapy for advanced breast cancer: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of a breast cancer screening programme on quality-adjusted life-years

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Bayesian approach to stochastic cost-effectiveness analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of letrozole in the treatment of advanced breast cancer in postmenopausal women in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic overview of cost-utility assessments in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/12696991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200321070-00006

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44404530&oldid=2021325185"